Preimplantation Genetic Diagnosis May Pose Neurological Risks
By Medical News Today,
Medical News Today
| 07. 23. 2009
Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. However, a new long-term analysis of PGD in mice suggests that this procedure may increase risks of weight gain and memory decline in adulthood.
PGD is used alongside assisted reproduction technologies to ensure couples that may be carriers of genetic disease (e.g. Ashkenazi Jews who have a high incidence of Tay-Sachs among their population) don't pass on defective genes to their children. While PGD is not believed to pose any serious health risks, the procedure does involve manipulating the developing embryo and no rigorous long-term studies have been carried out.
Ran Huo, Qi Zhou and colleagues used a mouse model to examine how a blastomere biopsy, as the key manipulation during the PGD procedure, could affect fetal, neonatal and adult development.
They found that there were no differences in embryo development prior to uterine implantation in the biopsied and control groups, which is consistent with results found in humans. However, following implantation, successful births from biopsied embryos were significantly lower than in...
Related Articles
By GMWatch Contributors, GMWatch | 11.21.2023
Open letter to UK's FSA is published
A group of experts representing business, farming, certification, academia, science and civil society have lodged a formal complaint against the UK’s Food Standards Agency (FSA), raising serious concerns about its public consultation process...
By Helen Floersh, Fierce Biotech | 11.10.2023
The images are unsettling, to put it mildly: a baby monkey whose skin grows eerily green, with glowing fingertips reminiscent of E.T.
This is “#10,” the world’s first live-born monkey that’s largely made up of embryonic stem cells, or ESCs...
Coded Bias is on Netflix; the trailer is
also at The Algorithmic Justice League
A few weeks ago, Marc Andreessen, a billionaire venture capitalist who got his start helping to create the first successful web browser, published The Techno-Optimist Manifesto on his website and caused something of a sensation. His screed characterizes Artificial Intelligence as, inter alia, “our alchemy, our Philosopher’s Stone” and “a universal problem solver.”
Not everyone agrees. In fact, the reaction of “techno-pessimists” (or realists) has been...
By Jonathan D. Grinstein, Genetic Engineering and Biotechnology News | 10.27.2023
Fyodor Urnov, PhD, is a pioneer in the field of genome editing and one of the scientists most invested in expanding the availability and utility of CRISPR-based therapies to the broadest possible population. He envisions a world in which genome...